Clinical Trial Update: A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the effect of Filgotinib in participants with active axial spondyloarthritis, with the trial cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Axial Spondyloarthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING